On March 31, 2014, Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) entered into a second amended and restated employment agreement with Kunwar Shailubhai, Ph.D., which amended and restated his previous agreement dated April 6, 2004, as amended and restated on June 25, 2012. Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) stock opened today at $4.67 and is currently trading at $4.71. The stock showed a negative weekly performance of -12.50%.
Pharmaceutical company Catalyst Pharmaceutical Partners (NASDAQ:CPRX) revealed on Tuesday the completion of its public offering at an offering price of USD2.21 per share. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) stock opened at $2.25, in current trading session and currently is at $2.29, by gaining 4.05%. The 52 week range of $0.45 – $3.65. Company’s market capitalization is 149.93 million.
Bernstein expects Johnson & Johnson (NYSE:JNJ) Q1 EPS to come in slightly above the consensus estimate, with strength in pharmaceuticals more than offsetting lackluster Medical Devices & Diagnostics growth, according to the firm. Bernstein keeps an Outperform rating on the stock. Johnson & Johnson (NYSE:JNJ) stock is currently trading at $97.91. The EPS of the stock is 4.81. Company’s market capitalization is 276.98 billion.
The sell-off of Pfizer Inc. (NYSE:PFE) stock due to clinical results for the company’s breast cancer drug, palbociclib, were unwarranted and created a buying opportunity as it made the already cheap pharmaceutical company even cheaper, Barron’s argues in its “Barron’s Take” column. Pfizer Inc. (NYSE:PFE) stock opened the session at $30.99, and now is at $30.82. The 52 week range of the Pfizer Inc. (NYSE:PFE) stock remained $27.12 – $32.96 and the day range was $30.62 – $31.03.